Inquiry Basket
Polymer-Based Drug Delivery Development Services
Drug Delivery Solutions
BOC Sciences provides integrated drug delivery solutions that connect polymer material design, carrier engineering, formulation optimization, drug conjugation, and analytical evaluation. We help researchers and pharmaceutical developers overcome delivery limitations associated with poorly soluble small molecules, biologics, nucleic acids, peptides, proteins, antibodies, cells, and viral vectors.
Integrated Support for Drug Delivery Projects
From polymer selection and carrier design to prototype formulation and release profiling, our services are designed to support early discovery, feasibility studies, formulation screening, and preclinical-stage delivery system development.
- Polymer selection and functional material design
- Nanocarrier, hydrogel, microsphere, and micelle development
- Drug loading, encapsulation, and conjugation optimization
- Physicochemical characterization and in vitro release evaluation
Comprehensive Drug Delivery Development Services
Drug delivery technologies are essential for improving the therapeutic performance of modern pharmaceuticals. Many promising drug candidates fail to achieve their expected clinical value because of poor solubility, rapid degradation, limited permeability, insufficient tissue distribution, or unacceptable toxicity. A well-designed delivery system can improve pharmacokinetics, protect fragile molecules, enable controlled release, and increase therapeutic exposure at the desired site of action.
BOC Sciences supports clients with a polymer-centered drug delivery development platform. Our expertise includes biodegradable polymers, PEG derivatives, functional copolymers, natural polymers, stimuli-responsive materials, and polymeric carrier systems. These capabilities allow us to develop tailored delivery solutions for small molecules, peptides, proteins, antibodies, DNA, RNA, cells, viral vectors, vaccines, and other advanced therapeutic modalities.
Formulation Feasibility
We help evaluate whether a drug candidate is suitable for polymeric nanoparticles, micelles, microspheres, hydrogels, conjugates, or other carrier systems. Feasibility studies may include solubility assessment, carrier compatibility, loading strategy, preliminary release behavior, and formulation stability considerations.
Delivery System Engineering
Our scientists design polymer-based delivery systems with tunable size, surface chemistry, degradation behavior, and release kinetics. Depending on the project goal, we can support controlled release, sustained release, targeted delivery, long-acting delivery, depot formulation, and biologics protection.
Development-Oriented Support
Beyond preparing prototype formulations, we provide structured data packages including characterization results, loading efficiency, encapsulation performance, release profiles, stability observations, and optimization recommendations to support the next stage of formulation development.
Key Challenges in Drug Delivery Development
Developing an effective drug delivery system requires balancing material properties, drug characteristics, biological barriers, manufacturing feasibility, and therapeutic requirements. Each dosage form and therapeutic modality presents different challenges, which is why platform selection and formulation design must be customized.
Poor Solubility and Bioavailability
Many drug candidates have poor aqueous solubility or limited permeability, restricting absorption and exposure. Polymeric carriers can improve dispersion, apparent solubility, and bioavailability.
Short Half-Life and Rapid Clearance
Peptides, proteins, nucleic acids, and biologics are often rapidly degraded or cleared. Polymer carriers and conjugation strategies can protect fragile molecules and prolong circulation.
Limited Targeting Efficiency
Selective accumulation in tumors, ocular tissues, immune cells, or intracellular compartments is difficult. Ligand-functionalized and charge-tuned carriers can improve targeting.
Uncontrolled or Burst Release
Some systems release drug too quickly or fail to sustain exposure. Polymer composition, degradation rate, crosslinking density, and morphology all affect release behavior.
Biological Barrier Penetration
Carriers may need to cross mucus, skin, epithelial, ocular, endosomal, or blood-brain barriers. Size, charge, surface chemistry, and hydrophilicity must be optimized.
Formulation Instability
Nanocarriers and biologic formulations may aggregate, precipitate, leak drug, or lose activity. Early stability screening helps identify robust formulation candidates.
Our Polymer Solutions for Drug Delivery Applications
BOC Sciences provides polymer materials, polymer modification services, and polymer-based carrier development solutions to support diverse drug delivery applications. Rather than acting as a full drug formulation developer, we focus on the polymer science and material engineering aspects that enable controlled release, targeted delivery, biomacromolecule stabilization, and advanced carrier construction. Our expertise helps researchers identify, design, synthesize, and optimize polymer systems tailored to specific drug delivery challenges.
Polymer Solutions for Route-Specific Delivery
Different administration routes impose unique requirements on polymer materials, including biocompatibility, degradation behavior, mucoadhesion, permeability enhancement, injectability, and tissue retention. We provide polymer selection, functionalization, and carrier development support to facilitate route-specific drug delivery applications.
- Injectable Polymer Delivery Solutions
- Oral Polymer Delivery Solutions
- Ocular Drug Delivery Solutions
- Transdermal Drug Delivery Solutions
Polymer Solutions for Controlled & Targeted Delivery
Advanced drug delivery often relies on precisely engineered polymers to regulate drug release, improve targeting efficiency, prolong circulation time, or enable depot formation. We support the development of functional polymer systems that help achieve sustained exposure and site-specific delivery objectives.
- Controlled Release Delivery Solutions
- Targeted Polymer Delivery Solutions
- Sustained-Release Delivery Solutions
- Long-Acting Drug Delivery Solutions
- Depot Formulation Development Solutions
- Drug Conjugation Solutions
Polymer Solutions for Biomacromolecule Delivery
Biomacromolecules frequently face challenges related to instability, degradation, immunogenicity, and poor intracellular transport. Through polymer conjugation, encapsulation technologies, and functional carrier design, we help improve protection, delivery efficiency, and biological performance for advanced therapeutic modalities.
- Peptide Delivery Solutions
- Protein Delivery Solutions
- Antibody Delivery Solutions
- DNA Delivery Solutions
- RNA Delivery Solutions
- Cells Delivery Solutions
- Viral Vector Delivery Solutions
- Enzymes Delivery Solutions
- Aptamer Delivery Solutions
Polymeric Carrier Platform Development
We provide custom synthesis and development support for a broad range of polymer-based carrier platforms. By controlling polymer composition, architecture, molecular weight, surface functionality, and degradation profiles, we help researchers build carrier systems optimized for specific drug delivery objectives.
- Polymer Nanoparticle Development
- Polymer Micelle Development
- Polymer Microsphere Development
- Polymer Hydrogel Development
- Polymer Nanogel Development
- Polymer Vesicle Development
- Polymer Microcapsule Development
Need Help Selecting the Right Delivery Platform?
Share your drug type, administration route, target release profile, and formulation challenges with our scientists. We can help evaluate whether a polymeric nanoparticle, micelle, microsphere, hydrogel, conjugate, or alternative delivery system is better suited for your project.
Polymer Technologies Supporting Drug Delivery
Polymer selection is one of the most important steps in delivery system development. The polymer determines carrier formation, drug compatibility, degradation behavior, mechanical properties, surface characteristics, and release kinetics. BOC Sciences provides broad polymer chemistry capabilities to support custom delivery system design.
Biodegradable Polymers
Biodegradable polymers are widely used for sustained-release injections, implants, nanoparticles, microspheres, and depot formulations. They can gradually degrade into biocompatible byproducts while controlling drug release over extended periods.
- PLGA
- PLA
- PCL
- Polyanhydrides
PEG-Based Materials
PEG and PEG derivatives are frequently used to improve solubility, reduce protein adsorption, extend circulation time, and provide functional handles for conjugation. PEGylated polymers are valuable for nanoparticles, micelles, protein conjugates, and long-circulating carriers.
- Linear PEG
- Multi-arm PEG
- PEG-NHS, PEG-MAL, PEG-SH
- Functional PEG linkers
Natural Polymers
Natural polymers offer biocompatibility, bioactivity, and functional groups suitable for chemical modification. They are commonly used in hydrogels, mucoadhesive systems, wound delivery materials, ocular formulations, and targeted nanocarriers.
- Chitosan
- Hyaluronic Acid
- Dextran
- Alginate
Stimuli-Responsive Polymers
Stimuli-responsive polymers can respond to environmental triggers such as pH, temperature, redox potential, enzymes, or light. These systems are useful for site-specific release, tumor microenvironment targeting, intracellular delivery, and on-demand therapeutic activation.
- pH-responsive polymers
- Thermoresponsive polymers
- Redox-responsive polymers
- Enzyme-responsive polymers
Functional Copolymers
Copolymers allow fine control over hydrophilic-hydrophobic balance, self-assembly, mechanical properties, and degradation rate. They can be designed as block, graft, random, star, or amphiphilic polymers for diverse delivery platforms.
- PEG-PLGA
- PEG-PCL
- PEG-PLA
- Block and graft copolymers
Surface-Functional Materials
Surface-functional polymers enable conjugation with ligands, antibodies, peptides, aptamers, imaging probes, or responsive linkers. These materials are essential for targeted delivery, diagnostic delivery systems, and multifunctional nanomedicine design.
- Amino-functional polymers
- Carboxyl-functional polymers
- Thiol-functional polymers
- Click chemistry-compatible polymers
Drug Delivery Development Workflow
Our workflow is designed to translate a therapeutic challenge into a practical delivery system development plan. Each project can be customized based on drug properties, delivery route, target indication, development stage, analytical requirements, and intended downstream use.
Project Consultation
We review drug properties, target product profile, delivery route, release goals, formulation issues, project timeline, and expected development outputs. This first step helps clarify whether the project requires material selection, carrier construction, formulation screening, drug conjugation, or a more integrated delivery system development plan.
Material Selection
Suitable polymers, excipients, functional groups, and carrier systems are selected based on drug compatibility, route requirements, release goals, stability considerations, and performance needs. Material selection may compare biodegradable polymers, PEG-based materials, natural polymers, functional copolymers, or stimuli-responsive systems.
Polymer Design
Custom polymers can be designed with controlled molecular weight, monomer composition, architecture, degradability, hydrophilicity, and reactive functionality. This enables downstream carrier construction, ligand conjugation, drug loading optimization, and release behavior tuning for project-specific delivery requirements.
Carrier Development
We prepare nanoparticles, micelles, microspheres, hydrogels, nanogels, microcapsules, vesicles, or conjugates using preparation methods matched to the drug and formulation target. Carrier development focuses on structure formation, particle or network properties, compatibility, and preliminary manufacturability.
Drug Loading
Encapsulation, adsorption, complexation, or covalent conjugation methods are screened and optimized to improve loading efficiency, formulation stability, and release performance. The loading strategy is selected based on drug solubility, charge, molecular size, functional groups, and sensitivity to processing conditions.
Characterization
Particle size, morphology, molecular weight, loading efficiency, surface charge, composition, and preliminary stability are evaluated to compare formulation candidates. These data help determine whether the carrier system meets the intended delivery route, release profile, and development-stage requirements.
Release Evaluation
In vitro release studies help assess burst release, sustained release, degradation-related release, and kinetic behavior under project-specific testing conditions. Release data can be used to compare candidate formulations, adjust polymer composition, and guide optimization of carrier structure or processing conditions.
Optimization Support
We provide recommendations for formulation refinement, polymer adjustment, process improvement, additional screening, and scale-up considerations for the next development stage. Optimization may focus on release profile control, loading improvement, carrier stability, reproducibility, or preparation of stronger feasibility data packages.
Deliverables from Our Drug Delivery Services
BOC Sciences provides project-specific deliverables that help clients evaluate formulation feasibility, compare delivery platforms, select lead formulations, and prepare for further preclinical research. Deliverables can be customized depending on whether the project is exploratory, optimization-focused, or intended for downstream development.
Delivery Strategy Report
Includes drug property assessment, administration route considerations, carrier platform recommendation, potential risks, and a practical development roadmap.
Customized Carrier Design
Provides polymer structure proposal, functional group selection, molecular weight guidance, composition recommendation, and expected release strategy.
Prototype Formulations
May include nanoparticles, micelles, microspheres, nanogels, hydrogels, microcapsules, vesicles, or conjugated delivery systems.
Drug Loading Data
Reports loading capacity, encapsulation efficiency, drug-to-carrier ratio, loading method comparison, and formulation screening results.
Characterization Report
Covers particle size, PDI, zeta potential, morphology, molecular weight, polymer composition, thermal properties, and chemical structure.
In Vitro Release Profile
Includes release kinetics, burst release assessment, sustained-release performance, degradation-related release behavior, and comparative release curves.
Stability Evaluation
May include physical stability, storage stability, aggregation behavior, leakage assessment, precipitation observation, and formulation robustness analysis.
Optimization Recommendations
Provides suggestions for polymer modification, formulation adjustment, processing refinement, scale-up planning, and next-step development priorities.
Characterization & Analytical Support
Reliable analytical data are essential for understanding how a drug delivery system is formed, how it behaves during storage, and how it releases drug under relevant conditions. BOC Sciences supports polymer, carrier, and formulation characterization to help clients make data-driven formulation decisions.
Polymer Analysis
Polymer analysis helps confirm whether the material meets the intended structure, molecular weight, purity, and thermal behavior requirements. These data are especially important when custom polymers are used as functional excipients or carrier materials.
- GPC / SEC
- NMR
- FTIR
- DSC and TGA
- Composition analysis
Carrier Characterization
Carrier characterization provides insight into particle formation, colloidal stability, morphology, surface properties, and loading performance. These parameters are critical for comparing candidate formulations and identifying the most promising delivery system.
- Particle size and PDI
- Zeta potential
- Morphology analysis
- Drug loading efficiency
- Encapsulation efficiency
Release & Stability Testing
Release and stability studies help determine whether a formulation can maintain drug integrity and provide the desired exposure profile. Testing conditions can be designed based on dosage form, target route, and project requirements.
- In vitro release testing
- Storage stability
- Degradation studies
- Drug leakage evaluation
- Aggregation assessment
Therapeutic Areas We Support
Our drug delivery services can be applied across multiple therapeutic areas where improved exposure, localized delivery, controlled release, tissue targeting, or biologic protection is needed. Each application area can be supported with customized polymer and carrier design strategies.
Oncology
Polymeric carriers, targeted nanoparticles, drug conjugates, and controlled-release systems can support anticancer small molecules, biologics, and combination therapies by improving tumor exposure, reducing systemic toxicity, and enabling controlled local or systemic delivery.
Gene Therapy
Carrier systems can be designed to protect DNA, RNA, and gene-editing components while improving cellular uptake, intracellular trafficking, and release. Polymer-based systems may support early screening of non-viral delivery approaches.
Vaccines
Polymeric and particulate systems can support antigen delivery, adjuvant co-delivery, nucleic acid vaccine development, and immune response modulation through carrier design, particle engineering, and controlled release strategies.
Ophthalmology
Ocular delivery systems may improve retention time, local exposure, and sustained release for anterior or posterior segment applications. Hydrogels, nanoparticles, and biodegradable systems can be explored for localized ocular therapy.
CNS Disorders
Barrier-aware delivery strategies can be explored for improving brain exposure, reducing systemic toxicity, or supporting local CNS delivery approaches. Polymer design may help tune carrier size, surface properties, and release behavior.
Rare Diseases
Customized delivery systems can support orphan drug development where limited dosing flexibility, fragile molecules, challenging routes, or special release requirements demand tailored polymer materials and formulation strategies.
Why Choose BOC Sciences for Drug Delivery Solutions?
BOC Sciences combines polymer chemistry expertise, custom material development, carrier engineering, formulation screening, and analytical support to help clients move from delivery concept to practical prototype formulation. Our service model is designed for flexibility, scientific collaboration, and project-specific problem solving.
Strong Polymer Chemistry Foundation
Our experience in monomer, polymer, PEG derivative, biodegradable polymer, and functional copolymer development allows us to design materials around drug properties, carrier architecture, degradation behavior, and release requirements.
Integrated Material-to-Formulation Support
We support projects from polymer selection and custom synthesis to carrier construction, drug loading, characterization, and release evaluation, reducing the gap between material development and delivery system feasibility.
Customized Project Design
Each project can be tailored according to drug modality, administration route, target release duration, stability challenge, and intended development stage, rather than relying on a fixed formulation template.
Broad Delivery Platform Coverage
Our capabilities cover polymeric nanoparticles, micelles, microspheres, hydrogels, nanogels, vesicles, microcapsules, conjugates, and other polymer-enabled delivery systems for diverse applications.
Data-Driven Optimization
Characterization, loading efficiency, release behavior, stability observations, and material analysis are used to compare formulation candidates and guide rational optimization decisions.
Flexible Research-Stage Collaboration
Whether clients need feasibility assessment, prototype preparation, polymer modification, formulation screening, or analytical support, we can provide modular services aligned with early discovery and preclinical-stage development needs.
Frequently Asked Questions
The following questions address common considerations for clients evaluating polymer-based drug delivery development services.
What types of drug candidates can be supported by polymer-based delivery systems?
Polymer-based delivery systems can support poorly soluble small molecules, peptides, proteins, antibodies, nucleic acids, vaccines, enzymes, cells, and viral vectors. The appropriate platform depends on molecular size, stability, charge, solubility, administration route, target tissue, and desired release profile. BOC Sciences evaluates these factors before recommending a specific carrier strategy.
How do you choose between nanoparticles, micelles, microspheres, and hydrogels?
Platform selection depends on the therapeutic goal. Micelles are often suitable for hydrophobic drugs, nanoparticles can support targeted or intracellular delivery, microspheres are useful for long-acting release, and hydrogels can provide localized or injectable depot delivery. Drug properties, route, dose, and release duration are evaluated together.
Can BOC Sciences develop custom polymers for a specific delivery project?
Yes. BOC Sciences can support custom polymer design, synthesis, modification, and functionalization for drug delivery applications. Parameters such as molecular weight, monomer ratio, degradability, hydrophilicity, reactive groups, and architecture can be adjusted to improve drug compatibility, carrier formation, surface modification, or controlled-release performance.
What information is needed to start a drug delivery development project?
Useful starting information includes drug structure or modality, solubility, stability, molecular weight, dose range, intended route, target release duration, desired dosage form, available analytical methods, and known formulation issues. If complete data are not available, BOC Sciences can begin with a feasibility assessment and material screening plan.
Do your services include drug loading and in vitro release testing?
Yes. Drug loading, encapsulation, conjugation, and in vitro release evaluation can be included depending on project requirements. We can compare loading methods, measure loading capacity and encapsulation efficiency, assess burst release, monitor sustained release behavior, and provide formulation optimization recommendations based on the data generated.
Are these services suitable for early-stage formulation screening?
Yes. Many projects begin with early-stage screening to compare carrier platforms, polymer materials, drug loading strategies, and release profiles. This approach helps identify promising formulation directions before committing to larger development work. Screening deliverables may include prototype formulations, characterization data, release profiles, and recommendations for next-step optimization.
Submit Your Drug Delivery Project Inquiry
Please share your drug delivery challenge, therapeutic modality, preferred administration route, target release profile, and any available formulation data. Our team will review your requirements and help propose a suitable polymer-based development strategy.
- Carrier selection and feasibility evaluation
- Custom polymer or functional material design
- Prototype formulation and characterization
- Drug loading, release testing, and optimization support
